Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism Read more

Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug Read more

Chutes & Ladders—Neumora shuffles leadership ahead of IND Read more

Navid Gholampour

Navid has over a decade of experience in Life Sciences recruitment. He partners with leaders to build patient-focused and innovative organisation